Market News

Jefferies analyst Corey Tarlowe upgrades Steven Madden (NASDAQ:SHOO) from Underperform to Hold and announces $36 price target.

Cantor Fitzgerald analyst Jay Kornreich maintains CTO Realty Growth (NYSE:CTO) with a Overweight and lowers the price target from $25 to $23.

Prestige Consumer Healthcare Inc (PBH) beat sales and earnings expectations with revenue of $336.3 million, though Clear Eyes production volatility an...

Vistance Networks Inc (VISN) posted 283% adjusted EPS growth and a debt-free balance sheet, but cut full-year EBITDA guidance on memory chip costs and...

MDA Space Ltd (MDA) posted strong third-quarter results, raised full-year 2026 guidance, and outlined growth from strategic acquisitions despite margi...

DraftKings shares are trading lower Friday after it reported worse-than-expected Q3 results late Thursday and lowered its FY26 guidance.

Manulife has been notified of an unsolicited mini-tender offer made by Ocehan LLC (Ocehan) to purchase up to 100,000 Manulife common shares, or less t...

FS KKR Capital Corp (FSK) posted $0.46 per share in net investment income and repurchased $90 million of stock, while navigating a $0.19 NAV decline a...

Rayonier Inc (RYN) posted $145 million in adjusted EBITDA and $287 million in CAD through nine months, fueled by PotlatchDeltic contributions and a $3...

Wall Street analysts adjusted price targets and ratings for BlackLine, GXO Logistics, Karman, Helios, Wendy’s, Applied Optoelectronics and others.

Perma-Fix Environmental Services Inc (PESI) posted strong sequential revenue growth and a 25% backlog increase, but a wider net loss and DFLAW shipmen...

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $340 price target.

"TCIM is profoundly disappointed that Devon has concluded its strategic review and determined that not selling additional assets represents the be...

A lawyer-turned-retailer got fired from the discount chain he built over two decades, and the warehouse he opened next with a handful of friends and a...

https://edge.media-server.com/mmc/p/sopgp9zf/

Cantor Fitzgerald analyst Josh Schimmer maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Overweight and lowers the price target from $30 to $20.

2026-11-06. The following slide deck was published by ArcelorMittal S.A.

-SEC Filing

Cloudflare beat Q3 estimates, raised full-year guidance, and shares surged 19.9%; analysts cut price targets despite strong results.

Investment combines U.S. entertainment and women’s sports content with VEON’s digital platforms and Jungo TV’s distribution across 65 countries New Yo...